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Abstract
Ketamine, one of the commonly used agents in pediatric anesthesia, has been linked to 
neurodegeneration and cognitive dysfunction in developing animal models. Previous 
studies on developing neurons derived from human embryonic stem cells (hESCs) 
indicate that ketamine induces neuroapoptosis and the mechanisms remain largely 
unknown. This study aims to investigate the effect of ketamine on intracellular calcium, 
mitochondrial signaling, and microRNA profiles in hESCs-derived 2-week-old neurons. 
The neurons were exposed to ketamine for 6 or 24 hours. Neuroapoptosis was assessed 
by TUNEL staining. Intracellular calcium level was analyzed using Fluo-4 AM staining. 
The mitochondria-related neuroapoptosis pathway including mitochondrial membrane 
potential, cytochrome c release from mitochondria to cytosol, and mitochondrial fission 
was also investigated. miScript miRNA arrays were used in microRNA target identifica-
tion studies. The results showed that ketamine exposure induced neuroapoptosis and 
alterations in intracellular calcium levels. In addition, ketamine decreased mitochondrial 
membrane potential, resulted in cytochrome c release from mitochondria into cytosol, 
and increased mitochondrial fission. Among 88 microRNAs investigated, let-7a/e, miR-
21, miR-23b, miR-28-5p, and miR-423-5p were found downregulated, while miR-96 was 
upregulated in the neurons treated with ketamine. Collectively, our findings indicate 
that ketamine induces neuroapoptosis possibly through the dysregulated intracellular 
calcium, mitochondria, and microRNA pathway.
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1. Introduction
Studies performed in a variety of animal models including mice and rhesus monkeys have 
found that prolonged exposure of developing animals to most inhalational and intravenous 
anesthetic agents including sevoflurane, isoflurane, ketamine, propofol and anesthetic com-
binations induce neuroapoptosis [1–3]. The period of rapid synaptogenesis has been linked 
to the time of greatest vulnerability in developing brains to anesthetic-induced neurotoxicity 
[4–6]. The period of rapid brain growth in mice peaks at roughly 7 days after birth while 
this time frame in humans ranges from late in pregnancy until the 2nd or 3rd year of life 
[7, 8]. The neuroapoptosis observed in the growing brains of the young animals was also 
found to be coupled to long-term memory and learning deficits. For example, Shen and col-
leagues noted significant deficiencies in both memory and spatial learning in postnatal day 
3 Sprague–Dawley rats following exposure to 1% sevoflurane. Their studies relied on the 
Morris water maze test to assess spatial learning/memory in the animals. Additionally, they 
found that these effects were both exposure number and dose dependent. They also observed 
that 7-week-old (adult) rats were insensitive to sevoflurane exposure with both the control 
and sevoflurane exposed animals displaying comparable results in the Water maze test [3]. 
The results of this study confirm that vulnerability to anesthetics is confined to an early period 
in development.
The many animal studies have raised concerns regarding the applicability of the models to 
humans. Of particular concern are the many rodent studies in which hemodynamic proper-
ties were not properly controlled. While extensive studies in rhesus macaques, a non-human 
primate model have been performed [9–14], a suitable human model in the study of anes-
thetic-induced neurotoxicity is currently lacking and exposure of young children to anesthet-
ics for study purposes would be unethical. Several human epidemiologic studies have been 
performed and many have suggested a link between anesthetic exposure in young children 
and learning and behavioral abnormalities when compared to their unexposed counterparts 
[15–17]. However, the human epidemiologic studies face many confounding variables that 
are often difficult to properly account for, leaving the results of these studies uncertain. While 
many of these studies are still ongoing, it is imperative to develop a proper human model to 
assess the effects of anesthetics in young children. Our study aimed to identify an appropriate 
human model to assess the effects of anesthetics on the developing human brain and also to 
dissect out the mechanisms behind the toxicity.
Human embryonic stem cells (hESCs) are derived from the inner cell mass of a human blasto-
cyst. In 1998 James Thompson and colleagues at the University of Wisconsin-Madison devel-
oped a technique to isolate and culture hESCs in vitro [18]. The formative work of this group 
opened up the possibility for mechanistic-based studies using a human cell line, effectively 
eliminating the potential concerns regarding the relevancy of studies using animal models to 
humans. hESCs are immature, divide indefinitely and are capable of generating cells from all 
three germ layers which makes these cells an ideal model of early human neurons once dif-
ferentiated. Using hESC-derived neurons has provided us with a reasonable human model by 
which to study anesthetic-induced developmental neurotoxicity.
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While many anesthetic agents are used clinically in the pediatric population, we choose to 
study the effects of the widely used anesthetic ketamine on our model of hESC-derived neu-
rons. Ketamine is an N-methyl-D-aspartate-receptor antagonist and provides pain relief and 
sedation in children undergoing a variety of procedures. Additionally, ketamine is a drug 
that is often abused and abuse of ketamine during pregnancy is of concern for the developing 
brain of the fetus [19]. Despite the many studies implicating the negative effects of anesthetic 
agents on developing brains, the mechanisms behind the toxicity remain largely unknown. 
Possible roles of neuroinflammation, reactive oxygen species production, epigenetic changes, 
and calcium signaling in the mechanism of anesthetic-induced neurotoxicity have all been 
suggested [20–23]. However, considerable work remains to fully elucidate the mechanisms 
behind the neuronal toxicity. In this study, we investigated the effect of ketamine on the cell 
viability, intracellular calcium level, mitochondrial signaling, and microRNA profile using 
the hESC-derived developing human neuron model.
Proper maintenance of intracellular calcium levels is critical for nearly every cellular process. 
In neurons, calcium is involved in the regulation of electrical activity, cell growth, metabolic 
activity, and many other processes [24]. Several studies have suggested that aberrant intra-
cellular calcium level in neurons plays a critical role in the neuronal degeneration observed 
in many different neurological disorders [25]. The dysregulated intracellular calcium might 
induce the neurotoxicity through mitochondrial signaling. Mitochondria are highly dynamic 
organelles that undergo continuous cycles of fusion and fission in order to maintain cellu-
lar homeostasis. Mitochondrial fusion and fission result in a change in mitochondrial shape: 
either elongated, tubular, interconnected mitochondrial networks, or fragmented and dis-
continuous mitochondria, respectively. Unbalanced fission-fusion can lead to various patho-
logical processes including neurodegeneration [26–29]. Shifting the balance towards fission 
has been associated with neuronal death in age-related neurodegenerative disease and brain 
injury [30, 31]. Inhibition of mitochondrial fission attenuated glutamate-induced neuronal 
death [31], translating to an increase in cell survival in the presence of oxidative stress [32]. 
Recent studies from Dr. Jevtovic’s groups have shown that mitochondrial fission plays an 
important role in anesthetic neurotoxicity. The increased mitochondrial fission was found in 
neonatal rat brains after a sedative dose of midazolam followed by combined nitrous oxide 
and isoflurane anesthesia for 6 h [33].
MicroRNAs are small, non-coding RNAs that function as negative regulators of gene expres-
sion. MicroRNAs are transcribed in hairpin structures in the nucleus by RNA polymerase 
II and the pri-miRNA produced is processed by the enzyme Drosha to cleave off a single 
hairpin loop. This forms the pre-miRNA which is exported to the cytoplasm. Once in the cyto-
plasm, the pre-miRNA is further processed to remove the hairpin loop and forms the mature 
microRNA strand. The mature microRNA strand then incorporates into an RNA-induced 
silencing complex where it can act to promote silencing of its target genes [34, 35]. Over 1000 
microRNAs have been discovered in humans and they have been shown to play an important 
role in nearly every cellular process. Dysregulation of microRNAs has also been linked to 
several diseases including certain cancers [36]. The role of microRNAs in anesthetic-induced 
neurotoxicity is just beginning to be studied.
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This chapter will outline: (1) the use of hESCs as a model system to study anesthetic-induced neu-
rotoxicity in the developing human brain, (2) the protocols involved in dissecting the mechanisms 
behind anesthetic-induced developmental neurotoxicity. We have focused on the role of dereg-
ulated intracellular calcium, mitochondrial signaling (e.g., mitochondrial membrane potential, 
cytochrome c release from mitochondria into cytosol, and mitochondrial fission), and microR-
NAs, and (3) a brief discussion on the possible role of intracellular calcium levels, mitochondrial 
signaling, and altered microRNA profiles in ketamine-induced developmental neurotoxicity.
2. Materials and methods
2.1. Stem cell culture and neuronal differentiation
hESCs (H1 cell line, WiCell Research Institute Inc., Madison, WI) were cultured on a 
feeder layer of mouse embryonic fibroblasts (MEFs) that were mitotically inactivated 
using mitomycin C (Sigma-Aldrich, St. Louis, MO) in hESC media containing DMEM/
F12 supplemented with, 1% nonessential amino acids, 20% Knockout serum (Gibco), 
1 mM L-glutamine, 4 ng/mL human recombinant basic fibroblast growth factor (bFGF, 
Invitrogen), 1% penicillin–streptomycin (Invitrogen) and 0.1 mM β-mercaptoethanol 
(Sigma-Aldrich). The media was changed daily and the cells were mechanically passaged 
every 5–6 days. For the studies described in this chapter, hESCs at passage 55–70 were 
used. To generate neurons, the hESCs were taken through a four-step differentiation pro-
tocol. The hESCs were dissociated using the protease Dispase (1.5 unit/mL, Invitrogen). 
The hESCs were then cultured in ultra-low attachment six-well plates (Corning Inc., 
Corning, NY) in a normoxic incubator (20% O2/5% CO2, 37°C). The media was changed once per day and spherical embryoid bodies (EBs) were present 24 h after dispase diges-
tion. Five days after digestion, EBs were moved to neural induction media containing 
DMEM/F12 supplemented with 1% N2 (Invitrogen), 1% nonessential amino acids, 1 mg/mL heparin (Sigma) and 5 ng/mL bFGF. On day 9, the EBs were plated to matrigel-coated 
35-mm dishes. Rosette-like structures were present within 5 days of the EBs plating down. 
The rosettes were manually separated from the surrounding cells using a serological 
pipette approximately 2 days after the morphology was clearly visible. The rosette cells 
were then transferred to matrigel-coated culture dishes and cultured in neural expan-
sion media containing DMEM/F12 supplemented with 2% B27 without vitamin A, 1% N2 (Invitrogen), 1% nonessential amino acids, 20 ng/mL bFGF and 1 mg/mL heparin. The 
neural stem cells (NSCs) were passaged enzymatically every 5 days. NSCs were cultured 
in 60-mm matrigel-coated dishes (500,000 cells/dish) in neuron differentiation media con-
taining neurobasal media (Gibco) supplemented with 2% B27, 100 ng/mL ascorbic acid 
(Sigma-Aldrich), 0.1 μM cyclic adenosine monophosphate, 10 ng/mL brain-derived neuro-
trophic factor, 10 ng/mL insulin-like growth factor 1 (PeproTech Inc., Rocky Hill, NJ) and 
10 ng/mL glial cell-derived neurotrophic factor. The media was changed every other day. 
Following 2 weeks of culture, the cells displayed clear neuronal morphology and were 
used for the studies.
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2.2. Neuronal characterization by immunofluorescence staining
hESC-derived neurons cultured on matrigel-coated, glass coverslips for 2 weeks were fixed 
for 30 min in 1% paraformaldehyde at room temperature. The cells were then washed with 
phosphate-buffered saline (PBS). Next, the cells were incubated for 15 min in 0.5% Triton 
X-100 (Sigma-Aldrich) in PBS. The cells were washed once again with PBS and blocked for 
20 min with 10% donkey serum at room temperature. The cells were then incubated with the 
primary antibodies [microtubule-associated protein 2 (MAP2), β-tubulin III or doublecortin 
(Abcam, Cambridge, MA)] for 1 h in a humidified, 37°C incubator. The cells were washed 
with PBS and incubated for 45 min with Alexa Fluor 488 or 594 donkey anti-mouse or rabbit 
immunoglobulin G (Invitrogen) secondary antibodies at 37°C. The cell nuclei were stained 
with Hoechst 33342 (Invitrogen). The coverslips were then mounted onto glass slides and 
imaged using a laser-scanning confocal microscope (Nikon Eclipse TE2000-U, Nikon Inc., 
Melville, NY).
2.3. Ketamine exposure
While the brain concentration of ketamine in humans during the induction and mainte-
nance of anesthesia is not well understood, reports have found that the peak blood levels 
of ketamine could be as high as 103 μM. The levels required to maintain anesthesia are 
typically in the range of 10–20 μM. hESC-derived neurons were exposed to 6 h of 20 μM 
ketamine or neurobasal media as a vehicle-control in a 5% CO2 incubator with normoxic 
conditions only for the microRNA studies. For all remaining studies, the cells were exposed 
to 24 h of 20 or 100 μM ketamine or neurobasal media as the vehicle control in the same 
incubator.
2.4. Assessment of cell death by TUNEL staining
Apoptosis of the hESC-derived neurons was assessed using a cell death detection kit (Roche 
Applied Bio Sciences, Indianapolis, IN) based on terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate in situ nick end labeling (TUNEL) following directions 
provided by the manufacturer. This kit identifies single or double-stranded DNA breaks by 
labeling the free 3′-OH termini with altered nucleotides in a reaction with terminal deoxy-
nucleotidyl transferase (TdT). Cells cultured on glass coverslips were exposed to ketamine 
or control conditions, rinsed and fixed with 1% paraformaldehyde. DNA fragmentation was 
analyzed using TdT, which incorporates into sites of DNA breaks. The nuclei were stained 
with Hoechst 33342 and the cells were imaged using the confocal microscope. Apoptosis/
necrosis was quantified by assessing the ratio of TUNEL-positive nuclei to total cell nuclei 
in a field.
2.5. Calcium imaging
Neurons were plated on matrigel-coated glass coverslips for the calcium imaging studies. 
Intracellular calcium was assayed using Fluo-4AM (Thermo Fisher Scientific). Neurons were 
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loaded with 2 μM Fluo-4AM for 30 min in the presence/absence of ketamine at 37°C followed 
by a 20-min washout deesterification. The coverslips were placed in a polycarbonate record-
ing chamber (Warner Instruments) on the stage of a laser-scanning confocal microscope. 
Fluo-4AM fluorescence (λ
ex
/λ
em
 = 485/520 nm) was visualized using the confocal microscope 
and the studies were completed in under 8 min to ensure minimal confounding stress to the 
cells. Fluorescent intensity was then quantified using ImageJ software 1.41 (Wayne Rasband; 
National Institutes of Health).
2.6. Mitochondrial membrane potential (ΔΨ
m
) assay
hESC-derived neurons cultured on glass coverslips were incubated with 50 nM tetrameth-
ylrhodamine ethyl ester (TMRE) (Thermo Fisher Scientific) for 20 min at room temperature. 
TMRE fluorescent intensity representing ΔΨ
m
 was recorded using the confocal microscope 
(Nikon). Images were obtained from six random fields per coverslip. The data were analyzed 
using ImageJ software.
2.7. Analysis of release of cytochrome c from mitochondria into cytosol
NSCs were cultured in neuronal differentiation medium. Ten days later, the differentiated 
neurons were transduced with the virus CellLight™ mitochondria-green fluorescence pro-
tein (GFP) (Thermo Fisher Scientific) for 24 h to label mitochondria. This fluorescent protein-
based reagent contains the leader sequence of E1-α pyruvate dehydrogenase fused to emerald 
GFP. The transduced neurons expressed GFP within mitochondria. Four days later, the 
labeled neurons were used for analysis of the effect of ketamine on the cytochrome c transloca-
tion. Virus transduction efficiency was calculated as the ratio between GFP-positive cells and 
total cells. GFP expression in mitochondria was confirmed by the colocalization of GFP and 
TMRE fluorescence signals within cells. The distribution of cytochrome c in the neurons was 
analyzed using immunofluorescence staining with antibody against cytochrome c (Abcam).
2.8. Assessment of mitochondrial shape by electron microscopy
hESC-derived neurons were cultured on matrigel-coated plastic coverslips and were exposed 
to either 20 μM or 100 μM ketamine or control conditions for 24 h. The cells were fixed at 4°C 
with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer and postfixed for 1 h on ice with 1% 
osmium tetroxide. The cells were rinsed with distilled water and dehydrated using acetonitrile 
and graded methanol (50%, 20 min; 70%, 20 min; 95%, 20 min; 100% 3×, 20 min). The cells were 
embedded in epoxy resin (EMbed-812, Electron Microscopy Sciences, Hatfield, PA) and polym-
erized at 70°C overnight. Thin (60 nm) sections were cut and the sections were stained with lead 
citrate and uranyl acetate. The samples were imaged using a Hitachi H600 Electron Microscope.
2.9. RNA extraction and cDNA preparation
Following exposure to ketamine or control conditions, total RNA was extracted using an RNeasy 
mini kit (Qiagen, Valencia, CA). Briefly, the cells were rinsed with PBS and lysed with QIAzol lysis 
reagent (Qiagen). Chloroform was added and the lysates were centrifuged. The upper phase was 
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removed and RNA was precipitated from it with 100% ethanol. The RNA was collected using the 
RNeasy spin columns (Qiagen). The samples were rinsed with buffer RPE. To elute the RNA from 
the column, 30 μL of RNase-free water (Qiagen) was added. An Epoch nanodrop spectrophotom-
eter (BioTek Instruments Inc., Winooski, VT) was used to assess the quantity and quality of the 
RNA in each sample. Each RNA sample was then diluted to 100 ng/μL in RNase-free water. The 
RNA was reverse transcribed to cDNA using the miScript II RT kit (Qiagen) following the manu-
facturer’s directions. Briefly, a mixture containing 1 μg of RNA, RNase-free water, 10× miScript 
nucleics mix, reverse transcriptase mix and 5× HiSpec buffer (Qiagen) was prepared. The RT reac-
tion mixture was incubated for 1 h at 37°C and for 5 min at 95°C to stop the reaction. The RT product 
was diluted in 200 μL in RNase-free water which yielded a final RNA concentration of 4.5 ng/μL 
in each sample.
2.10. Quantitative reverse transcription-PCR (qRT-PCR) analysis of MicroRNAs
To screen for potential microRNAs contributing to the ketamine-induced neurotoxicity, we 
used human miFinder miRNA PCR arrays (Qiagen) which screen 84 microRNAs. For the 
arrays, a master mix (25 μL/well) containing the template cDNA (4.5 ng/well), RNase-free 
water, universal primer and miScript SYBR Green (Qiagen) was prepared according to the 
manufacturer’s instructions. The primers for each microRNAs to be analyzed come lyophi-
lized in the wells of the array plates. To confirm the array results, validation assays were 
performed in which the three cDNA samples used for the arrays were each run in triplicate 
on the same PCR run. The PCR was run using a BioRad iCycler for 15 min at 95°C followed 
by 40 cycles of: denaturation (15 s at 94°C), annealing (30 s at 55°C) and extension (30 s at 
70°C). Melt curve and reverse transcriptase controls were run to ensure sample purity and 
primer specificity, respectively. The epoch nanodrop spectrophotometer was also used to 
assess RNA quality using the A260:A280 ratio. To be considered pure, the A260:A280 for an 
RNA sample must fall between 1.8 and 2.2. Samples with an A260:A280 ratio outside of this 
accepted range were not used for the studies. MicroRNAs that displayed a 1.3 fold change in 
expression between the ketamine and control treated cells were considered to be of interest.
2.11. Statistical analysis
The data presented in this chapter was all collected from at least 3 independent neuronal dif-
ferentiations. Values were reported as means ± the standard deviation with normal distribu-
tions. Statistical analysis was completed using the Student’s t-test when comparing 2 groups. 
All statistical analysis was performed using the SigmaStat 3.5 software (Systat Software, Inc., 
San Jose, CA).
3. Results and discussion
3.1. Neuronal differentiation and characterization
To generate neurons from the hESCs, the cells were taken through a four-step differentia-
tion protocol as outlined in Figure 1A and described previously [20, 37, 38]. The neurons 
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exhibited a characteristic neuronal morphology with small cell bodies and long projections. 
The neurons also formed extensive, interconnected networks over time. The cells displayed 
a very distinct morphology at each stage of the differentiation protocol. The hESCs formed 
tight colonies when cultured on a feeder layer and the EBs formed three-dimensional aggre-
gates when suspended in culture media. At the neural rosette stage, the NSCs formed tightly 
packed arrangements with a characteristic design and were bordered by several additional 
cell types. Once mechanically separated from the surrounding non-NSCs and digested, the 
NSCs separated from one another and spread out on the matrigel-coated dishes. At this point, 
the cells proliferated extensively.
The neurons were immunostained after 2 weeks in differentiation media and expressed the 
neuron-specific markers MAP2 and β-tubulin III and formed synapses as assessed by the 
positive staining of Synapsin I. Based upon the immunostaining, the differentiation protocol 
was 90–95% efficient in the generation of neurons. In an attempt to better gauge the maturity 
level of the hESC-derived neurons, the cells were also immunostained for doublecortin, a 
marker of immature/migrating neurons. In assessing the staining results, most of the neu-
rons in culture (90–95%) were positive for this marker of immature neurons (Figure 1B) 
which suggests that this model system is a valuable representation of developing human 
neurons.
Figure 1. Differentiation protocol and confocal images of immunolabeled human embryonic stem cell (hESC)-derived 
neurons. (A) Neurons were derived from hESCs through a four step differentiation protocol. (B) Neurons were stained 
with antibodies against the neuron-specific proteins, microtubule-associated protein 2 (MAP2) and β-tubulin III to assess 
the differentiation efficiency, and doublecortin to confirm the immaturity of the neurons [37].
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3.2. Ketamine-induced apoptosis
TUNEL staining was used to assess cell death in hESC-derived neurons following ketamine 
exposure by labeling breaks in the DNA. The cells were exposed to 100 μM ketamine or con-
trol conditions for 24 h. The number of TUNEL-positive cells was significantly increased 
when compared to control treated cells following ketamine exposure (Figure 2). These find-
ings confirm many of the previously published animal studies which have shown increased 
neuronal cell death following exposure of the developing brain to ketamine [39]. We focused 
on the investigation of the effect of ketamine on the intracellular calcium level, mitochon-
drial signaling, and microRNA expression in order to understand the mechanisms governing 
ketamine-induced cell death.
3.3. Alterations in intracellular calcium levels
Following exposure of 2-week-old hESC-derived neurons to 100 μM ketamine or control 
conditions for 24 h, the intracellular calcium levels in the cells were assessed using Fluo-4AM 
fluorescence. The intracellular calcium levels were significantly elevated in the ketamine-
treated cells when compared to control treatment (Figure 3). Calcium is a critical ion in the 
body and is fundamental in proper neuronal functioning. In neurons, calcium is crucial in 
synaptic activity and plasticity, cell signaling, neurotransmitter release and is involved in 
nearly every aspect of the cell cycle [24]. The careful balance of intracellular calcium levels is 
crucial to cell survival. Calcium homeostasis dysregulation, in particular calcium overload 
in the cell, has been linked to many different neurodegenerative diseases [25]. The findings 
from this study suggest that disrupted intracellular calcium homeostasis may also be linked 
to ketamine-induced cell death in developing neurons which could prove to be a novel thera-
peutic target.
3.4. Ketamine induces neuronal apoptosis via mitochondrial pathway
The mitochondria are extremely important organelles involved in many cellular processes 
including energy production, cell signaling, and apoptosis [40–46]. Given that ketamine may 
Figure 2. Exposure to 100 μM ketamine for 24 h induced significant cell death in the hESC-derived neurons. Ketamine 
induced an increase in the number of TUNEL-positive cells indicating significant cell death when compared to control-
treated cells. *P < 0.05 vs. control. n = 3 for each group.
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cause mitochondrial damage, we measured ΔΨ
m
 and distribution of cytochrome c in the cells. 
Treatment of hESC-derived neurons with 100 μM ketamine for 24 h significantly decreased 
ΔΨ
m
 (Figure 4A). In order to investigate the distribution of cytochrome c within the cells, 
the neurons were transduced with the virus CellLight™ mitochondria-GFP (green). GFP and 
TMRE signals were colocalized in the cells (Figure 4B), confirming that successfully labeling 
of mitochondria with GFP. GFP-positive cells reached 40% (Figure 4C). The distribution of 
cytochrome c in mitochondria and cytosol was examined using immunofluorescence stain-
ing. The results showed that cytochrome c was located within mitochondria in the control 
culture (Figure 4D). However, in the ketamine-treated cells, cytochrome c was released from 
the mitochondria into cytosol.
Neuroapoptosis is a commonly recognized harmful effect by anesthetics with mecha-
nisms that are not fully understood. Apoptosis is a programmed cell death. Cytochrome 
c release from mitochondria precededing the loss of ∆Ψ
m
 is a key event in initiating mito-
chondria-involved apoptosis [47], eventually leading to the typical alterations related to 
apoptosis such as DNA fragmentation in cell nuclei [48, 49]. In this study, following ket-
amine exposure, there was a significantly increase in the TUNEL-positive apoptotic cells 
(Figure 2). Ketamine-induced cell death was accompanied by the significant decrease in 
∆Ψ
m
 and the increased cytochrome c release from mitochondria into cytosol (Figure 4). 
These data were in agreement with those previously reported by others [48, 50–52], sug-
gesting that ketamine induces human neuron to undergo mitochondria-mediated apop-
tosis pathway.
To maintain proper cellular function, the mitochondria continuously undergo cycles of fusion 
and fission. Unbalanced fusion/fission, particularly excessive fission/fragmentation can lead 
to various pathological conditions including neurodegeneration [53]. To assess mitochon-
drial fission shape in the hESC-derived neurons following exposure to ketamine, electron 
microscopy was used. The neurons were exposed to either 20 μM or 100 μM ketamine or 
control conditions for 24 h. The cells were then prepared and imaged on an electron micro-
scope. The mitochondria appeared considerably fragmented in the ketamine- treated neurons 
when compared to control cells (Figure 5). Increased mitochondrial fission has been linked 
to the propofol-induced cell death in hESC-derived neurons as previously published by our 
group [54]. Our findings suggest that ketamine exposure results in an increase of mitochon-
drial fission within the developing neurons, which may contribute to the increased cell death 
observed in the ketamine-treated group.
Figure 3. Ketamine exposure for 24 h induced elevated cytosolic Ca2+ [(Ca2+)
c
] of neurons. (A) Ketamine increased (Ca2+)
c
. 
Neurons were loaded with the Ca2+ indicator Fluo-4AM. The fluorescence images of free cytosolic Ca2+ in the 2-week-old 
differentiated neurons are shown. (B) Ketamine (100 μM, 24 h) significantly increased (Ca2+)
c
 (**P < 0.01, n = 3).
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Figure 4. Ketamine decreases mitochondrial membrane potential (ΔΨ
m
) and increases cytochrome c release from mitochondria 
into cytosol. (A) ΔΨ
m
 assay. Ketamine (100 Μm) treatment for 24 h decreased ΔΨ
m
 (*P < 0.05 vs. control, n = 3). (B) Labeling 
mitochondria of neurons with CellLight™ mitochondria-green fluorescence protein (GFP) reagent. The GFP-positive cells 
were loaded with TMRE. GFP expression in mitochondria was confirmed by the colocalization of tetramethylrhodamine 
ethyl ester (TMRE/mitochondrial probe) and GFP signals within the cells. (C) Representative fluorescent images of the 
neurons transduced with CellLight™ mitochondria-GFP reagent. Blue are cell nuclei. 40% cells were GFP positive. (D) the 
effect of ketamine on the distribution of cytochrome c in neurons. Cells were labeled with CellLight™ mitochondria-GFP 
reagent expressed GFP in mitochondria and then treated with ketamine (100 μM, 24 h). The distribution of cytochrome c 
in cells was analyzed by immunofluorescence staining. Column 1 is the image of mitochondria; column 2 is the image of 
cytochrome c; and column 3 is the merged image. The inset in the top corner of each image is the magnified box indicated 
by white arrows. The orange signals in the merged images indicate the existence of cytochrome c inside the mitochondria, 
and the signals in the merged images indicate the existence of cytochrome c outside the mitochondria. Ketamine treatment 
(100 μM, 24 h) increased cytochrome c release from mitochondria into cytosol. Note: The cytochrome c signals (indicated by blue 
arrows) that do not overlap with GFP florescence were from non-transduced cells. Scale bar = 10 μm [20].
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3.5. qRT-PCR analysis of microRNA expression
Our lab was the first to show the role of microRNAs, specifically miR-21 in propofol-induced 
neurotoxicity in hESC-derived neurons [37]. Using a similar approach, we have identified 
several microRNAs with altered expression profiles in ketamine-treated hESC-derived neu-
rons when compared to control-treated cells suggesting a role of microRNAs in ketamine-
induced neurotoxicity. A total of 84 of the most abundantly expressed microRNAs were 
analyzed using the miFinder miRNA PCR arrays. A fold change of 1.3 between the control 
and ketamine-treated cells was considered significant. The data are expressed as percent of 
control with the control group set to 100%. The expression of seven microRNAs was found 
to be significantly altered following exposure to 6 h of ketamine when compared to control-
treated cells. Of these seven, only miR-96 was found to be significantly upregulated with 
ketamine treatment. The remaining microRNAs (miRs-Let 7A, Let 7E, 21, 23b, 28-5p, 423-5p) 
were significantly downregulated with ketamine exposure compared to control-treated cells 
(Figure 6). Of these microRNAs, the downregulation of miR-21 was of particular interest since 
miR-21 is protective against ischemic injuries [55]. Downregulation of a protective microRNA 
may provide a mechanism by which ketamine is inducing neuronal toxicity in the hESC-
derived neurons. Interestingly, we also reported a significant downregulation of miR-21 in 
hESC-derived neurons following exposure to the anesthetic propofol and went on to confirm 
a functional role of this expression change in the propofol-induced neurotoxicity [37]. This 
research suggests that the mechanism of anesthetic-induced neurotoxicity among multiple 
anesthetic agents might converge on altered expression of microRNAs such as miR-21. While 
the other 6 microRNAs identified through these array studies have not been implicated pre-
viously in neuronal diseases, this approach has the potential to uncover novel roles of these 
microRNAs in ketamine-induced neurotoxicity. An aim of future studies will include func-
tional studies to further elucidate the role of these microRNAs and the signaling components 
connecting these altered microRNAs and attenuated mitochondrial function in ketamine-
induced neurotoxicity. Additionally, the current microRNA studies were done using a dif-
ferent time point (6 h) than the cell death and mitochondrial studies previously mentioned 
which used a time point of 24 h. This was done to ensure any potentially transient changes in 
microRNA expression were observed. Future studies will include the addition of microRNA 
Figure 5. Ketamine increases mitochondrial fission as evidenced by the electron microscope images of differentiated 
neurons treated with the indicated concentrations (20 and 100 μM) of ketamine for 24 h. Scale bars = 500 nm.
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expression changes following exposure to 24 h of ketamine along with additional cell death 
and mitochondrial signaling assays following 6 h of exposure to ketamine which will allow 
for proper interpretation of the results.
3.6. Summary
The mechanisms governing anesthetic-induced neurotoxicity in the developing brain are 
currently not well understood and this research has been limited by the lack of an appropri-
ate human model. Collectively, the findings from this study indicate that (1) hESC-derived 
neurons represent a promising model to investigate the effects of anesthetic exposure 
in the developing human brain, (2) ketamine induces neuroapoptosis via mitochondrial 
pathway, and (3) dysregulation of intracellular calcium, increased mitochondrial fission, 
and altered microRNA expression might play important roles in ketamine-induced neu-
roapoptosis. The role of microRNAs in anesthetic-induced neurotoxicity is just beginning 
to be understood. Functional studies including knockdown and overexpression of microR-
NAs of interest will further establish their role in the ketamine-induced neurotoxicity. 
Additionally, much work remains to establish a functional link between dysregulation of 
intracellular calcium, increased mitochondrial fission, decreased mitochondrial membrane 
potential, altered microRNA expression, and the observed neuroapoptosis. These studies 
are very promising and may reveal novel mechanisms of ketamine-induced developmental 
neurotoxicity.
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